Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain-containing protein 30B (ANKRD30B) is a protein encoded by the human *ANKRD30B* gene. The protein contains ankyrin repeat domains that typically mediate protein-protein interactions critical for cellular function in various protein families[5][6]. While the exact biological function of ANKRD30B is not clearly established, its expression has been associated with breast cancer (as serologically defined antigen NY-BR-1.1) and spastic ataxia 4[2]. ANKRD30B does not belong to classical molecular families such as receptors, enzymes, or transcription factors—rather, it is classified as an ankyrin repeat-containing protein. No approved drugs are known to interact with ANKRD30B, nor is it a recognized therapeutic target. Its potential utility as a biomarker in breast cancer and related research is noted[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain-containing protein 30B (ANKRD30B).